Ginkgo Bioworks Holdings, Inc. (DNA) stock
DNANYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3013% below fair value
$8.44+0.12 (+1.44%)
Close on Nov 18, 2026Market cap $568.35MP/E –Yield –
Ginkgo Bioworks market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Ginkgo Bioworks's market cap was $653.04M on Nov 11, 2026, against $527.44M a year earlier. Over the last 5 years it ranged from $309.88M to $12.35B, with a median of $1.07B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $653.04M | +38.3% |
| 2025 | Dec 31, 2025 | $472.31M | -9.4% |
| 2024 | Dec 31, 2024 | $521.27M | -84.4% |
| 2023 | Dec 29, 2023 | $3.33B | +19.7% |
| 2022 | Dec 30, 2022 | $2.79B | -77.5% |
| 2021 | Dec 31, 2021 | $12.35B | – |
See a number that looks wrong?